Trial intelligence / Profile preview

Vitamin C and iPRF for TMJ Pain

NCT06345092Completed

Sponsor
Cairo University
Start
Apr 2024
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ascorbic acid in temporomandibular joint internal derangement (TMJID), sponsored by Cairo University. Primary endpoint: Pain management at 16 weeks. Started Apr 2024; status: completed.

02

Drugs

ascorbic acid
03

Conditions

temporomandibular joint internal derangement (TMJID)

Beyond the preview

Go deeper on NCT06345092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06345092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call